Gene expression levels of glycogen synthase kinase 3β interacting protein ninein (NIN) and Low-density lipoprotein receptor (LDLR) are altered in NAFLD + PCOS group. This evidence concerns the gene VLDLR and metabolic dysfunction-associated steatotic liver disease.